IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BAI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.272
NA - Nord America 5.066
AS - Asia 4.035
SA - Sud America 441
AF - Africa 114
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.956
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.836
IT - Italia 1.598
GB - Regno Unito 1.372
SG - Singapore 1.149
CN - Cina 1.123
DE - Germania 565
BD - Bangladesh 478
HK - Hong Kong 345
BR - Brasile 331
FR - Francia 316
VN - Vietnam 312
RU - Federazione Russa 308
SE - Svezia 282
NL - Olanda 215
IN - India 181
FI - Finlandia 180
CA - Canada 166
TR - Turchia 116
ID - Indonesia 93
IE - Irlanda 92
ES - Italia 61
KR - Corea 50
JP - Giappone 40
PL - Polonia 35
UA - Ucraina 34
DK - Danimarca 32
CH - Svizzera 31
CI - Costa d'Avorio 31
AR - Argentina 29
BE - Belgio 28
MX - Messico 28
ZA - Sudafrica 26
AU - Australia 22
TW - Taiwan 21
CO - Colombia 20
AT - Austria 19
IQ - Iraq 19
CL - Cile 18
GR - Grecia 17
EU - Europa 15
EC - Ecuador 12
MY - Malesia 11
EG - Egitto 10
ET - Etiopia 10
MA - Marocco 10
PH - Filippine 10
PK - Pakistan 10
TH - Thailandia 10
UZ - Uzbekistan 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
NO - Norvegia 9
JM - Giamaica 8
PT - Portogallo 8
IR - Iran 7
LU - Lussemburgo 7
RO - Romania 7
IL - Israele 6
JO - Giordania 6
KE - Kenya 6
LT - Lituania 6
MK - Macedonia 6
PE - Perù 6
PY - Paraguay 6
RS - Serbia 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
GT - Guatemala 5
HU - Ungheria 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
CR - Costa Rica 4
SN - Senegal 4
TN - Tunisia 4
CD - Congo 3
EE - Estonia 3
HN - Honduras 3
HR - Croazia 3
PS - Palestinian Territory 3
SC - Seychelles 3
UY - Uruguay 3
CW - ???statistics.table.value.countryCode.CW??? 2
DZ - Algeria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
SV - El Salvador 2
UG - Uganda 2
VG - Isole Vergini Britanniche 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
Totale 14.947
Salva come PNG Salva come JPEG
Città #
Southend 1.222
Singapore 661
Ashburn 560
Dallas 454
Milan 394
Chandler 333
Hong Kong 313
San Jose 259
Frankfurt am Main 243
Fairfield 240
Beijing 210
Council Bluffs 157
Wilmington 153
Ann Arbor 151
Los Angeles 147
Santa Clara 137
New York 127
Seattle 122
Rome 121
Helsinki 115
Houston 114
Woodbridge 107
Princeton 100
Ho Chi Minh City 91
Dublin 88
Hefei 87
Toronto 84
Jakarta 77
Boardman 76
Hanoi 76
Buffalo 65
Cambridge 63
Lauterbourg 63
Munich 61
Moscow 60
Dearborn 59
The Dalles 58
Bengaluru 55
Istanbul 50
Turin 48
Guangzhou 47
Columbus 43
Phoenix 40
Shanghai 40
Nanjing 38
Groningen 36
Naples 35
Cagliari 33
São Paulo 33
Tokyo 33
Des Moines 32
Abidjan 31
Chicago 31
Florence 31
Mountain View 31
Redwood City 28
Cangzhou 25
Nuremberg 25
Seoul 24
Warsaw 24
Brussels 23
Grafing 23
Palermo 23
Mumbai 22
Turku 22
Lappeenranta 21
San Diego 21
Madrid 20
Redmond 20
Amsterdam 19
Bologna 19
Da Nang 19
London 19
Hangzhou 18
Atlanta 17
Shenzhen 17
Orem 16
Paris 16
Washington 16
Berlin 15
Kiez 15
Montréal 15
Genoa 14
Quanzhou 14
Tianjin 14
Boston 13
Catania 13
Fuzhou 13
Haiphong 13
Montreal 13
Shenyang 13
Stockholm 13
Taipei 13
Zhengzhou 13
Jacksonville 12
Jinan 12
Perugia 12
Vienna 12
Bari 11
Düsseldorf 11
Totale 8.906
Salva come PNG Salva come JPEG
Nome #
HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS (HAND): PERFORMANCE OF ¿3 QUESTIONS TEST¿ AS SCREENING TEST, PREVALENCE, CLINICAL CORRELATES AND THERAPEUTIC APPROACH IN THE SAN PAOLO INFECTIOUS DISEASES¿ (SPID) COHORT. 770
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study). 474
HPV infection in a cohort of HIV-positive men and women : prevalence of oncogenic genotypes and predictors of mucosal damage at genital and oral sites 391
Maraviroc as Intensification Strategy in HIV-1 Positive Patients with Deficient Immunological Response: an Italian Randomized Clinical Trial 381
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 378
T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis 373
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances : results from a randomized controlled trial 348
Factors associated with HPV-DNA clearance in a cohort of HIV-positive patients : role of cART and gender 330
Reduced central memory CD4+ T cells and increased T-Cell activation characterise treatment-naive patients newly diagnosed at late stage of HIV infection 323
Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients 312
Impact of psychological intervention on anxiety, depression, and post-traumatic stress disorder: results from a longitudinal study of hospitalized Covid-19 patients = Impatto di un intervento psicologico su ansia, depressione e disturbo post-traumatico da stress: risultati di uno studio longitudinale su pazienti Covid-19 ospedalizzati 311
Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy 305
Assessment of radiological vertebral fractures in HIV-infected patients : clinical implications and predictive factors 299
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 294
A 20-year-old girl with an unusual febrile illness 292
Cognitive Neuro-Rehabilitation of HIV-Associated Neurocognitive Disorders : Case Reports of A New Computer-Based Restorative Approach In 3 Hiv-Positive Cart-Treated Patients 284
Association between abdominal aortic calcifications, bone mineral density and vertebral fractures in a cohort of HIV-positive patients 280
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes 271
Viro-immunological characterization of naïve patients with high cerebrospinal fluid (CSF) HIV RNA 267
Sensitivity of SARS-CoV-2 Detection With Nasopharyngeal Swabs 257
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A. : a modelling study 255
Association between CSF and peripheral markers of immune-activation/inflammation and elevated intrathecal HIV-RNA levels in a cohort of HIV-infected antiretroviral naıve individuals 254
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 251
Skewed T-cell maturation and function in HIV-infected patients failing CD4+ recovery upon long-term virologically suppressive HAART 250
Declining mortality rate of hospitalised patients in the second wave of the COVID-19 epidemics in Italy : Risk factors and the age-specific patterns 239
Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naïve HIV-infected patients 237
CD8+ hyperactivation and senescence correlate with early carotid intima-media thickness in HIV+ patients with no cardiovascular disease 234
The importance of patients’ case-mix for the correct interpretation of the hospital fatality rate in COVID-19 disease 224
Long-lasting cognitive abnormalities after COVID-19 224
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 224
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects 216
Female gender is associated with long COVID syndrome : a prospective cohort study 213
Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort 205
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19 203
Clinical effect of interleukin-2 (IL-2) immuno-adjuvant treatment in HIV+ advanced naïve patients 200
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms 198
Reduced CD127 expression on peripheral CD4+ T cells impairs immunological recovery in course of suppressive HAART 198
Do combination antiretroviral therapy regimens for HIV infection feature diverse T-Cell phenotypes and inflammatory profiles? 189
One‐Year Cognitive Follow‐Up of COVID‐19 Hospitalized Patients 182
Immune reconstitution in HIV+ subjects on Lopinavir/Ritonavir-based HAART according to the severity of pre-therapy CD4+ 179
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort 178
One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects 172
Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients 172
Association between tight junction proteins and cognitive performance in untreated persons with HIV 164
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromes 162
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015 160
Anxiety and depression symptoms after virological clearance of COVID-19: A cross-sectional study in Milan, Italy 158
Short and long-term trajectories of the post COVID-19 condition: Results from the EuCARE POSTCOVID study 157
CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patients 155
Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART) 155
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia 146
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV 144
CX3CR1 I249M280 heterozygosity is associated to contraction of HIV-specific immune responses in HIV-infected patients failing to recover CD4T-cell following long-term haart 143
Incidence, risk factors and impact on clinical outcomes of bloodstream infections in patients hospitalised with covid-19: A prospective cohort study 142
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 140
A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy 138
Effectiveness of hydroxychloroquine in COVID-19 disease : a done and dusted deal? 132
Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients 131
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations 131
Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals 128
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project 127
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project 123
Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19 Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project 122
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 116
Long-lasting cognitive impairment after COVID-19 114
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19 109
Prevalence of sub-clinical vertebral fractures in a cohort of HIV positive patients and ability of frax-score to identify patients at increased fracture risk 108
Renal microsporidiosis due to Encephalitozoon cuniculi in an HIV/AIDS patient with persistent fever and kidney injury 101
Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy 85
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities : Is it time to assess the definitions? 75
null 3
null 3
Totale 15.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.282 117 135 82 70 92 80 79 87 158 146 54 182
2022/20231.256 114 132 100 149 144 199 34 86 142 30 87 39
2023/20241.066 56 48 45 81 251 83 90 61 39 61 110 141
2024/20252.528 114 194 74 230 165 131 146 181 155 320 325 493
2025/20265.861 563 583 599 446 451 293 690 227 478 345 730 456
2026/2027213 213 0 0 0 0 0 0 0 0 0 0 0
Totale 15.409